RESUMEN
Background: Gokshura Moola (root of Tribulus terrestris Linn.) is one among the ingredients of Dashamoola, a group of ten medicinal plants principally comprising roots as the useful part. In practice instead of root, fruit of Gokshura is widely used in most of the preparations of Dashamoola in Kerala. Dashamoola occupies a significant role in a wide range of Ayurvedic formulations and holds a major share in the drug manufacturing industry. This high demand of Dashamoola, leads the use of fruit instead of its root and implies the need to compare the efficacy of root and fruit of Gokshura. Aim: This study is planned to assess whether fruit of Gokshura can be substituted for its root using the parameter of diuretic activity in Wistar albino rats. Materials and methods: Wistar albino rats were divided in to four groups. The group I control group and group II standard group was orally administered with carboxymethyl cellulose 2% in normal saline and furosemide (20 mg/kg) respectively. Group III was administered orally with decoction of Gokshura root and groups IV with Gokshura fruit decoction, with a dose of 8.64 ml/kg. The diuretic effect was evaluated by measuring urine volume, Na+, K+ and Cl- ion content in urine. The results were analyzed by applying one-way ANOVA and LSD Post hoc pairwise comparison test. Results: Both test drugs in group III and group IV provided significant increase in urine output when compared to the control group (P < 0.001). Decoction of Gokshura root provided a significant increase in comparison to decoction of Gokshura fruit in regards of sodium (P < 0.01), potassium (P < 0.001), and chloride ion (P < 0.05) excretion. Conclusion: Diuretic action of both root and fruit of Gokshura is similar in terms of urine volume, but root is more effective in the basis of ionic excretion. Hence, while treating patients suffering from ionic imbalance, it is better to use fruit of Gokshura for protecting the ionic balance during diuresis. In all other conditions, root can be used for a better diuretic activity.
RESUMEN
BACKGROUND: Traditional healing practitioners of South India use fine paste (an Ayurvedic dosage form known as 'kalka') of Lobelia alsinoides Lam., an ethno medicinal plant for curing hepatic diseases. OBJECTIVE: To evaluate in-vivo hepatoprotective effect of a candidate formulation viz. kalka containing whole plant (L. alsinoides Lam.) in rat model of Carbon-tetrachloride (CCl4) induced hepatotoxicity. MATERIALS & METHODS: Hepatotoxicity was induced in Wistar albino rats by oral administration of 1.25 ml/kg CCl4 once every day for 7 consecutive days. A candidate kalka formulation (fine paste) was prepared and administered to rats at different dose rates of 0.54 g/kg, 1.08 g/kg and 2.16 g/kg daily. At the end of the study-period, the serum levels of aspartate amino transferase (AST), alanine amino transferase (ALT), alkaline phosphatase (ALP), total bilirubin, total protein, albumin and total cholesterol were monitored. Further, the hepatic pathology was evaluated for assessing the extent of hepatotoxicity in the control and hepatoprotective effect in treatment groups. Meanwhile in-vitro antioxidant activity of kalka was evaluated by hydroxy radical, nitric oxide and DPPH (2, 2 diphenyl-1-picrylhydrazil) radical scavenging assays. Further, a 'limit test' was done in accordance with OECD Guidelines 425 (acute toxicity). RESULTS: The animals treated with the fine paste of L. alsinoides did not show an elevation in the biochemical values compared to CCl4 treated rats and during histomorphologic evaluation, hepatoprotective effect was evident with scattered mitotic figures in the parenchyma. Acute toxicity evaluation indicated that doses up to 2500 mg/kg are not toxic to rats. It has a good anti-oxidant activity also. CONCLUSIONS: From the study, it was obvious that L. alsinoides had significant hepatoprotective effect in CCl4 induced liver toxicity in rats. This ethno medicinal plant is certainly a promising hepatoprotective drug in liver disorders.
RESUMEN
Kerabala (CB) is a novel ayurvedic formulation used for treating various inflammatory diseases. This formulation was made from virgin coconut oil and it comprises extracts of Sida cordifolia, coconut milk and sesame oil. The current study was performed to evaluate the anti-inflammatory action of CB on carrageenan-induced acute and adjuvant-induced chronic experimental models. 5 mg/kg bwt was found to be potent dose from carrageenan model and evaluated its effect in adjuvant-induced chronic arthritic model. The antioxidant assays like SOD, catalase, glutathione peroxidase, lipid peroxidation product, nitrate level and GSH were measured in paw tissue. Hematological parameters like hemoglobin (HB) count, ESR, WBC count, plasma CRP levels were analyzed. By RT-PCR, the inflammatory markers like cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), tumor necrosis factor alpha (TNF-α) and interleukin 6 (IL-6) expressions were evaluated. The extracellular matrix proteins like MMP-2 and MMP-9 were determined by zymography and its expression by western blotting. Histopathology and cytology of paw tissue and synovium were analyzed. The result indicated that there was a significant increment in the levels of antioxidant enzymes on CB administration. The hematological markers such as ESR, WBC and plasma CRP levels were reduced by CB treatment and it also increases the HB level. The upregulated gene level expressions of inflammatory markers like COX-2, iNOS, TNF-α and IL-6 were down regulated by administration of CB. MMP-2 and MMP-9 expression significantly reduced by CB administration. Massive influx of inflammatory cell infiltration, proliferative collagen in histological analysis of paw tissue of arthritic rat was decreased by CB administration. Synovial cytology of CB administrated group shows reduced number of reactive mesothelial cells and synovial inflammatory cells. This current study shows that ayurvedic drug CB has an antioxidant, anti-inflammatory and anti-arthritic activity in experimental arthritic model. CB as an anti-arthritic drug has beneficial effect for treating inflammation, tissue damage and pain associated with arthritis.
Asunto(s)
Antiinflamatorios/uso terapéutico , Antioxidantes/uso terapéutico , Artritis Experimental/tratamiento farmacológico , Malvaceae , Aceites de Plantas/uso terapéutico , Aceite de Sésamo/uso terapéutico , Animales , Antiinflamatorios/química , Antiinflamatorios/aislamiento & purificación , Antioxidantes/química , Antioxidantes/aislamiento & purificación , Artritis Experimental/metabolismo , Artritis Experimental/patología , Aceite de Coco , Relación Dosis-Respuesta a Droga , Composición de Medicamentos , Masculino , Medicina Ayurvédica , Corteza de la Planta , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Aceites de Plantas/química , Aceites de Plantas/aislamiento & purificación , Raíces de Plantas , Ratas , Ratas Wistar , Aceite de Sésamo/aislamiento & purificación , Aceite de Sésamo/farmacología , Resultado del TratamientoRESUMEN
We evaluated the protective efficacy of the polyphenolic fraction from virgin coconut oil (PV) against adjuvant induced arthritic rats. Arthritis was induced by intradermal injection of complete Freund's adjuvant. The activities of inflammatory, antioxidant enzymes and lipid peroxidation were estimated. PV showed high percentage of edema inhibition at a dose of 80mg/kg on 21st day of adjuvant arthritis and is non toxic. The expression of inflammatory genes such as COX-2, iNOS, TNF-α and IL-6 and the concentration of thiobarbituric acid reactive substance were decreased by treatment with PV. Antioxidant enzymes were increased and on treatment with PV. The increased level of total WBC count and C-reactive protein in the arthritic animals was reduced in PV treated rats. Synovial cytology showed that inflammatory cells and reactive mesothelial cells were suppressed by PV. Histopathology of paw tissue showed less edema formation and cellular infiltration on supplementation with PV. Thus the results demonstrated the potential beneficiary effect of PV on adjuvant induced arthritis in rats and the mechanism behind this action is due to its antioxidant and anti-inflammatory effects.